Pulmonx Corporation

Equities

Market Closed - Nasdaq Other stock markets 20:00:00 13/03/2026 GMT			5-day change	1st Jan Change
1.680 ^USD	-5.62%		-16.83%	-23.98%

03-04	Pulmonx Corporation, Q4 2025 Earnings Call, Mar 04, 2026
03-04	Pulmonx announces closing of up to $60 million credit facility	RE

Published on 06/11/2025 at 04:35 pm BST - Modified on 06/11/2025 at 05:35 pm BST

S&P Capital IQ

Presenter Speech
Steven Williamson (Executives)

Good morning, everyone. My name is Steve Williamson. I'm the President and CEO of Pulmonx. Thanks for joining us today. I'll get started with a

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

03-04	Pulmonx Corporation, Q4 2025 Earnings Call, Mar 04, 2026
03-04	Pulmonx announces closing of up to $60 million credit facility	RE
03-04	Pulmonx Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
03-04	Pulmonx Corporation Provides Earnings Guidance for the Full Year of 2026	CI
03-04	Pulmonx Corporation Closes Five-Year Credit Facility for Up to $60 Million with Perceptive Advisors	CI
11-13	Pulmonx Corporation, Q3 2025 Earnings Call, Nov 12, 2025
11-12	Lung treatment firm Pulmonx's Q3 revenue up 5%, net loss narrows marginally	RE
11-12	Pulmonx Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11-12	Pulmonx Corporation Updates Earnings Guidance for the Full Year 2025	CI
27/10/25	Pulmonx announces management transition and preliminary third quarter 2025 revenue reschedules third quarter 2025 earnings call to November 12, 2025	RE
27/10/25	Pulmonx Corp - on October 21 Steven S. Williamson resigned as president and CEO of Pulmonx - SEC filing	RE
27/10/25	Pulmonx Corporation Announces CFO Changes	CI
27/10/25	Pulmonx Corporation Announces CEO Changes, Effective October 27, 2025	CI
27/10/25	Pulmonx Corporation Announces Executive Changes	CI
27/10/25	Pulmonx Corporation Provides Revenue Guidance for the Third Quarter of 2025	CI